204 related articles for article (PubMed ID: 27452128)
1. Glioblastoma multiforme targeted therapy: The Chlorotoxin story.
Cohen-Inbar O; Zaaroor M
J Clin Neurosci; 2016 Nov; 33():52-58. PubMed ID: 27452128
[TBL] [Abstract][Full Text] [Related]
2. Chlorotoxin modified morusin-PLGA nanoparticles for targeted glioblastoma therapy.
Agarwal S; Mohamed MS; Mizuki T; Maekawa T; Sakthi Kumar D
J Mater Chem B; 2019 Oct; 7(39):5896-5919. PubMed ID: 31423502
[TBL] [Abstract][Full Text] [Related]
3. A Combined Approach Employing Chlorotoxin-Nanovectors and Low Dose Radiation To Reach Infiltrating Tumor Niches in Glioblastoma.
Tamborini M; Locatelli E; Rasile M; Monaco I; Rodighiero S; Corradini I; Franchini MC; Passoni L; Matteoli M
ACS Nano; 2016 Feb; 10(2):2509-20. PubMed ID: 26745323
[TBL] [Abstract][Full Text] [Related]
4. Chlorotoxin: a helpful natural scorpion peptide to diagnose glioma and fight tumor invasion.
Dardevet L; Rani D; Aziz TA; Bazin I; Sabatier JM; Fadl M; Brambilla E; De Waard M
Toxins (Basel); 2015 Mar; 7(4):1079-101. PubMed ID: 25826056
[TBL] [Abstract][Full Text] [Related]
5. Chlorotoxin: Structure, activity, and potential uses in cancer therapy.
Ojeda PG; Wang CK; Craik DJ
Biopolymers; 2016 Jan; 106(1):25-36. PubMed ID: 26418522
[TBL] [Abstract][Full Text] [Related]
6. Chlorotoxin-A Multimodal Imaging Platform for Targeting Glioma Tumors.
Cohen G; Burks SR; Frank JA
Toxins (Basel); 2018 Nov; 10(12):. PubMed ID: 30486274
[TBL] [Abstract][Full Text] [Related]
7. Expression of voltage-activated chloride currents in acute slices of human gliomas.
Ullrich N; Bordey A; Gillespie GY; Sontheimer H
Neuroscience; 1998 Apr; 83(4):1161-73. PubMed ID: 9502255
[TBL] [Abstract][Full Text] [Related]
8. In Silico prediction of the molecular basis of ClTx and AaCTx interaction with matrix metalloproteinase-2 (MMP-2) to inhibit glioma cell invasion.
Othman H; Wieninger SA; ElAyeb M; Nilges M; Srairi-Abid N
J Biomol Struct Dyn; 2017 Oct; 35(13):2815-2829. PubMed ID: 27678152
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic Effects of Blue Scorpion Venom (Rhopalurus junceus) in a Glioblastoma Cell Line Model.
Lozano-Trujillo LA; Garzón-Perdomo DK; Vargas ACR; de Los Reyes LM; Avila-Rodriguez MF; Gay OTG; Turner LF
Curr Pharm Biotechnol; 2021; 22(5):636-645. PubMed ID: 32679017
[TBL] [Abstract][Full Text] [Related]
10. Targeted delivery of silver nanoparticles and alisertib: in vitro and in vivo synergistic effect against glioblastoma.
Locatelli E; Naddaka M; Uboldi C; Loudos G; Fragogeorgi E; Molinari V; Pucci A; Tsotakos T; Psimadas D; Ponti J; Franchini MC
Nanomedicine (Lond); 2014 May; 9(6):839-49. PubMed ID: 24433240
[TBL] [Abstract][Full Text] [Related]
11. Time-Resolved MRI Assessment of Convection-Enhanced Delivery by Targeted and Nontargeted Nanoparticles in a Human Glioblastoma Mouse Model.
Stephen ZR; Chiarelli PA; Revia RA; Wang K; Kievit F; Dayringer C; Jeon M; Ellenbogen R; Zhang M
Cancer Res; 2019 Sep; 79(18):4776-4786. PubMed ID: 31331912
[TBL] [Abstract][Full Text] [Related]
12. Chlorotoxin-conjugated nanoparticles for targeted imaging and therapy of glioma.
Zhao L; Shi X; Zhao J
Curr Top Med Chem; 2015; 15(13):1196-208. PubMed ID: 25858130
[TBL] [Abstract][Full Text] [Related]
13. Targeting Glioblastoma Cells Expressing CD44 with Liposomes Encapsulating Doxorubicin and Displaying Chlorotoxin-IgG Fc Fusion Protein.
Mahmud H; Kasai T; Khayrani AC; Asakura M; Oo AKK; Du J; Vaidyanath A; El-Ghlban S; Mizutani A; Seno A; Murakami H; Masuda J; Seno M
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495404
[TBL] [Abstract][Full Text] [Related]
14. Genetic engineering and characterisation of chlorotoxin-fused gelonin for enhanced glioblastoma therapy.
Park T; Min KA; Cheong H; Moon C; Shin MC
J Drug Target; 2019 Nov; 27(9):950-958. PubMed ID: 30156929
[TBL] [Abstract][Full Text] [Related]
15. Vesicular systems employing natural substances as promising drug candidates for MMP inhibition in glioblastoma: A nanotechnological approach.
Agarwal S; Muniyandi P; Maekawa T; Kumar DS
Int J Pharm; 2018 Nov; 551(1-2):339-361. PubMed ID: 30236647
[TBL] [Abstract][Full Text] [Related]
16. Identification of MMP-9 specific microRNA expression profile as potential targets of anti-invasion therapy in glioblastoma multiforme.
Yan W; Zhang W; Sun L; Liu Y; You G; Wang Y; Kang C; You Y; Jiang T
Brain Res; 2011 Sep; 1411():108-15. PubMed ID: 21831363
[TBL] [Abstract][Full Text] [Related]
17. MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma.
Costa PM; Cardoso AL; Custódia C; Cunha P; Pereira de Almeida L; Pedroso de Lima MC
J Control Release; 2015 Jun; 207():31-9. PubMed ID: 25861727
[TBL] [Abstract][Full Text] [Related]
18. PEITC inhibits human brain glioblastoma GBM 8401 cell migration and invasion through the inhibition of uPA, Rho A, and Ras with inhibition of MMP-2, -7 and -9 gene expression.
Chou YC; Chang MY; Wang MJ; Yu FS; Liu HC; Harnod T; Hung CH; Lee HT; Chung JG
Oncol Rep; 2015 Nov; 34(5):2489-96. PubMed ID: 26352173
[TBL] [Abstract][Full Text] [Related]
19. Structure-function study of a chlorotoxin-chimer and its activity on Kv1.3 channels.
Huys I; Waelkens E; Tytgat J
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Apr; 803(1):67-73. PubMed ID: 15025999
[TBL] [Abstract][Full Text] [Related]
20. A Novel Platinum-Maurocalcine Conjugate Induces Apoptosis of Human Glioblastoma Cells by Acting through the ROS-ERK/AKT-p53 Pathway.
Aroui S; Dardevet L; Ben Ajmia W; de Boisvilliers M; Perrin F; Laajimi A; Boumendjel A; Kenani A; Muller JM; De Waard M
Mol Pharm; 2015 Dec; 12(12):4336-48. PubMed ID: 26465677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
